Clinical TrialsSearch results
Number of results: 416
Completed
- The efficacy and safety of pyridoxamine in patients with autism spectrum disorder; Exploratory physician-led Phase 2 trial
- Autism Spectrum Disorder
- Kure Shigeo
- 2020-04-20
Completed
- Transvenous RFA for primary aldosteronism
- Left aldosterone producing adenoma.
- Takase Kei
- 2021-03-26
Recruiting
- A Global Study to Assess the Effects of Durvalumab with Oleclumab or Durvalumab with Monalizumab Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer
- Locally Advanced (Stage III), Unresectable Non-small Cell Lung Cancer
- Yamaji Shigeyuki
- 2022-03-05
Recruiting
- A multicenter prospective randomized study to evaluate the delivery timing safety and efficacy of AntiTachycardia Pacing
- Arrhythmias, Cardiac
- Ando Kenji
- 2023-05-15
Recruiting
- A Phase 3 study of Dostarlimab as Sequential Therapy after Chemoradiation compared to placebo in adult participants with Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- Ishibashi Hideyasu
- 2024-01-18
Recruiting
- A Phase 3 study of MK-7684A plus cCRT in Stage III NSCLC
- NSCLC
- Koh Yasuhiro
- 2022-07-02
Recruiting
- A Phase I/II Study of MT-2111 in Patients with Relapsed/Refractory DLBCL
- Patients with relapsed/refractory DLBCL
- Kazuoki Kondou
- 2022-11-22
Recruiting
- A phase II study of ipilimumab, nivolumab, and radiotherapy for advanced NSCLC
- Non-small cell lung cancer
- Miyauchi Eisaku
- 2022-04-19
Recruiting
- A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Nemolizumab in Patients with Acquired Reactive Perforating Collagenosis
- Acquired Reactive Perforating Collagenosis
- Tomoyuki Nishiura
- 2023-11-09
Recruiting
- A Randomised phase III clinical trial of combined therapy with CPT-11/CDDP versus CPT-11 alone in patients with advaneced or recurrent gastric cancer resistant to S-1
- Gastric Cancer
- ECRIN
- 2009-10-01